Home | All intervention

[RDF data]
Intervention #100133 (Drug:oxaliplatin, gemcitabine, bevacizumab)

Resource URI: http://static.linkedct.org/resource/intervention/100133
linkedct:description Gemcitabine 1000mg/m2 IV over 30 minutes, on days 1 and 8 followed by Oxaliplatin 130mg/m2 IV over 2 hours on day 1 followed by Bevacizumab 15 mg/kg IV over 90* minutes, on day 1 Cycles q 3 weeks x 4 cycles One cycle equals 3 weeks. Patients will be re-evaluated every 2 cycles. If CR, PR or SD, patients will continue treatment up to four cycles or until progression or unacceptable toxicity. Patients achieving CR, PR, or SD after 4 cycles will continue Bevacizumab maintenance: Bevacizumab 15 mg/kg IV q 3 weeks until relapse/progression
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00217282>
linkedct:intervention_id 100133 (xsd:int)
linkedct:intervention_name oxaliplatin, gemcitabine, bevacizumab
linkedct:intervention_type Drug
rdfs:label Intervention #100133 (Drug:oxaliplatin, gemcitabine, bevacizumab)
rdf:type linkedct:intervention